Asthma Clinical Trials in Charlotte, North Carolina

4 studies are recruiting for asthma in Charlotte, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

   The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety …

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Teva Investigational Site 12115, Charlotte, North Carolina

   Locations

   189 in total

   Run by

   Teva Branded Pharmaceutical Products R&D LLC

   See if you can join NCT06664619 on ClinicalTrials.gov

2. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

   The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   Research Site, Charlotte, North Carolina

   Locations

   150 in total

   Run by

   AstraZeneca

   See if you can join NCT06307665 on ClinicalTrials.gov

3. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

   The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning o…

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   American Health Research, Charlotte, North Carolina

   Locations

   132 in total

   Run by

   Pfizer

   See if you can join NCT06977581 on ClinicalTrials.gov

4. Individualizing Treatment for Asthma in Primary Care (Full Study)

   While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long…

   Stage

   Phase 4

   Ages

   13 to 75

   Site

   Atrium Health, Charlotte, North Carolina

   Locations

   13 in total

   Run by

   DARTNet Institute

   See if you can join NCT07052942 on ClinicalTrials.gov